The management challenges of a case with Flupentixol‐induced neuroleptic malignant syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12315
Abstract: Neuroleptic malignant syndrome (NMS) is a rare and life‐threatening reaction. The incidence rate of NMS has dropped because of the higher use of atypical antipsychotics, compared with the typical ones. The mortality rate in patients… read more here.
Keywords: neuroleptic malignant; case flupentixol; management challenges; flupentixol induced ... See more keywords